Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2151400rdf:typepubmed:Citationlld:pubmed
pubmed-article:2151400lifeskim:mentionsumls-concept:C0009170lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C0025611lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C0178601lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2151400lifeskim:mentionsumls-concept:C1555903lld:lifeskim
pubmed-article:2151400pubmed:issue4lld:pubmed
pubmed-article:2151400pubmed:dateCreated1991-7-17lld:pubmed
pubmed-article:2151400pubmed:abstractTextA study was performed to examine behavioral response to a challenge of selective dopamine D-1 and D-2 agonists in rats previously sensitized by subchronic administration of methamphetamine or cocaine. Rats in three groups received repeated injections (IP) of saline, methamphetamine (4 mg/kg/day) or cocaine (20 mg/kg/day), respectively, for 14 days. After an abstinence period of 7-13 days, all groups were challenged with either a selective D-1 agonist (SKF 38393) or D-2 agonists (quinpirole or RU 24213). The ability of SKF 38393 (6 mg/kg or 18 mg/kg) to produce grooming behavior did not differ significantly among the saline-, methamphetamine- and cocaine-treated groups. In contrast, quinpirole (1 mg/kg) and RU 24213 (3 mg/kg) produced more intense stereotypy consisting of rearing, sniffing and repetitive head movement in the two psychostimulant-treated groups than in the saline-treated group. Such augmented response to selective D-2 agonists was observed even after a 1-month abstinence period. These results suggest that the enduring behavioral sensitization induced by two pharmacologically distinct psychostimulant agents, methamphetamine and cocaine, occurs through a common neurobiological mechanism of lasting supersensitivity in postsynaptic D-2, but not D-1 dopamine receptors.lld:pubmed
pubmed-article:2151400pubmed:languageenglld:pubmed
pubmed-article:2151400pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:citationSubsetIMlld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2151400pubmed:statusMEDLINElld:pubmed
pubmed-article:2151400pubmed:issn0033-3158lld:pubmed
pubmed-article:2151400pubmed:authorpubmed-author:OtsukiSSlld:pubmed
pubmed-article:2151400pubmed:authorpubmed-author:AkiyamaKKlld:pubmed
pubmed-article:2151400pubmed:authorpubmed-author:UjikeHHlld:pubmed
pubmed-article:2151400pubmed:issnTypePrintlld:pubmed
pubmed-article:2151400pubmed:volume102lld:pubmed
pubmed-article:2151400pubmed:ownerNLMlld:pubmed
pubmed-article:2151400pubmed:authorsCompleteYlld:pubmed
pubmed-article:2151400pubmed:pagination459-64lld:pubmed
pubmed-article:2151400pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:meshHeadingpubmed-meshheading:2151400-...lld:pubmed
pubmed-article:2151400pubmed:year1990lld:pubmed
pubmed-article:2151400pubmed:articleTitleD-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine.lld:pubmed
pubmed-article:2151400pubmed:affiliationDepartment of Neuropsychiatry, Okayama University Medical School, Japan.lld:pubmed
pubmed-article:2151400pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2151400pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2151400lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2151400lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2151400lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2151400lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2151400lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2151400lld:pubmed